rs867401075
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005360.5(MAF):c.611G>T(p.Gly204Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00224 in 979,642 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G204S) has been classified as Uncertain significance.
Frequency
Consequence
NM_005360.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAF | NM_005360.5 | c.611G>T | p.Gly204Val | missense_variant | 1/2 | ENST00000326043.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAF | ENST00000326043.5 | c.611G>T | p.Gly204Val | missense_variant | 1/2 | 1 | NM_005360.5 | A2 | |
MAF | ENST00000569649.1 | c.611G>T | p.Gly204Val | missense_variant | 1/2 | 5 | P4 | ||
MAF | ENST00000393350.1 | c.611G>T | p.Gly204Val | missense_variant | 1/1 | A2 |
Frequencies
GnomAD3 genomes ? AF: 0.0106 AC: 1548AN: 145380Hom.: 28 Cov.: 30
GnomAD4 exome AF: 0.000771 AC: 643AN: 834256Hom.: 7 Cov.: 34 AF XY: 0.000737 AC XY: 284AN XY: 385358
GnomAD4 genome ? AF: 0.0107 AC: 1550AN: 145386Hom.: 28 Cov.: 30 AF XY: 0.0101 AC XY: 716AN XY: 70638
ClinVar
Submissions by phenotype
Ayme-Gripp syndrome;C1857768:Cataract 21 multiple types Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 16, 2024 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 29, 2022 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 10, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at